美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
72516-035-03	72516-035	HUMAN PRESCRIPTION DRUG	buPropion Hydrochloride XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20201001	N/A	ANDA	ANDA211200	Oryza pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	150 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-035-03)
72516-035-09	72516-035	HUMAN PRESCRIPTION DRUG	buPropion Hydrochloride XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20201001	N/A	ANDA	ANDA211200	Oryza pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	150 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-035-09)
72516-035-50	72516-035	HUMAN PRESCRIPTION DRUG	buPropion Hydrochloride XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20201001	N/A	ANDA	ANDA211200	Oryza pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	150 mg/1	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-035-50)
72516-036-03	72516-036	HUMAN PRESCRIPTION DRUG	buPropion Hydrochloride XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190906	N/A	ANDA	ANDA211200	Oryza pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	300 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-036-03)
72516-036-09	72516-036	HUMAN PRESCRIPTION DRUG	buPropion Hydrochloride XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190906	N/A	ANDA	ANDA211200	Oryza pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	300 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-036-09)
72516-036-50	72516-036	HUMAN PRESCRIPTION DRUG	buPropion Hydrochloride XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20190906	N/A	ANDA	ANDA211200	Oryza pharmaceuticals Inc.	BUPROPION HYDROCHLORIDE	300 mg/1	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-036-50)